APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Diagnostic Equipment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nuclear Medicine Diagnostic Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025193 pages

Choose your research edition.

Industry ResearchNuclear Medicine Diagnostic Equipment Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Diagnostic Equipment Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Diagnostic Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Diagnostic Equipment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Diagnostic Equipment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Diagnostic Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Medicine Diagnostic Equipment include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compañía Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nuclear Medicine Diagnostic Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Medicine Diagnostic Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Medicine Diagnostic Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nuclear Medicine Diagnostic Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Medicine Diagnostic Equipment Segment by Company

GE HealthCare

Siemens Healthineers

CMR Naviscan

Compañía Mexicana

DDD-Diagnostic

Digirad

Mediso Medical Imaging Systems

Philips

Positron

SurgicEye

TeraRecon

Toshiba

Top Grade Healthcare

Neusoft Group

United Imaging

MinFound Medical

SinoUnion Healthcare

Nuclear Medicine Diagnostic Equipment Segment by Type

PET

SPECT

Nuclear Medicine Diagnostic Equipment Segment by Application

Tumor Imaging

Endocrine System Imaging

Urinary System Imaging

Bone Marrow Imaging

Others

Nuclear Medicine Diagnostic Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nuclear Medicine Diagnostic Equipment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nuclear Medicine Diagnostic Equipment Industry Trends Table 2. Nuclear Medicine Diagnostic Equipment Industry Drivers Table 3. Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges Table 4. Nuclear Medicine Diagnostic Equipment Industry Restraints Table 5. Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nuclear Medicine Diagnostic Equipment Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Manufacturers Table 9. Global Nuclear Medicine Diagnostic Equipment Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Nuclear Medicine Diagnostic Equipment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nuclear Medicine Diagnostic Equipment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nuclear Medicine Diagnostic Equipment Manufacturers, Product Type & Application Table 13. Global Nuclear Medicine Diagnostic Equipment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nuclear Medicine Diagnostic Equipment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PET Table 17. Major Manufacturers of SPECT Table 18. Global Nuclear Medicine Diagnostic Equipment Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units) Table 20. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2027-2032) & (K Units) Table 21. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026) Table 22. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2027-2032) Table 23. Global Nuclear Medicine Diagnostic Equipment Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2026) & (K Units) Table 25. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2027-2032) & (K Units) Table 26. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026) Table 27. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Tumor Imaging Table 29. Major Manufacturers of Endocrine System Imaging Table 30. Major Manufacturers of Urinary System Imaging Table 31. Major Manufacturers of Bone Marrow Imaging Table 32. Major Manufacturers of Others Table 33. Global Nuclear Medicine Diagnostic Equipment Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units) Table 35. Global Nuclear Medicine Diagnostic Equipment Sales by Application (2027-2032) & (K Units) Table 36. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026) Table 37. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2027-2032) Table 38. Global Nuclear Medicine Diagnostic Equipment Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2026) & (K Units) Table 40. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2027-2032) & (K Units) Table 41. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2026) Table 42. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2027-2032) Table 43. Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026) & (K Units) Table 45. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2026) Table 46. Global Nuclear Medicine Diagnostic Equipment Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Nuclear Medicine Diagnostic Equipment Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 50. North America Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 51. Europe Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 53. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 60. Global Nuclear Medicine Diagnostic Equipment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2026) Table 64. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2027-2032) Table 65. GE HealthCare Company Information Table 66. GE HealthCare Business Overview Table 67. GE HealthCare Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 69. GE HealthCare Recent Development Table 70. Siemens Healthineers Company Information Table 71. Siemens Healthineers Business Overview Table 72. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio Table 74. Siemens Healthineers Recent Development Table 75. CMR Naviscan Company Information Table 76. CMR Naviscan Business Overview Table 77. CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio Table 79. CMR Naviscan Recent Development Table 80. Compañía Mexicana Company Information Table 81. Compañía Mexicana Business Overview Table 82. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio Table 84. Compañía Mexicana Recent Development Table 85. DDD-Diagnostic Company Information Table 86. DDD-Diagnostic Business Overview Table 87. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio Table 89. DDD-Diagnostic Recent Development Table 90. Digirad Company Information Table 91. Digirad Business Overview Table 92. Digirad Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio Table 94. Digirad Recent Development Table 95. Mediso Medical Imaging Systems Company Information Table 96. Mediso Medical Imaging Systems Business Overview Table 97. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio Table 99. Mediso Medical Imaging Systems Recent Development Table 100. Philips Company Information Table 101. Philips Business Overview Table 102. Philips Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Philips Nuclear Medicine Diagnostic Equipment Product Portfolio Table 104. Philips Recent Development Table 105. Positron Company Information Table 106. Positron Business Overview Table 107. Positron Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Positron Nuclear Medicine Diagnostic Equipment Product Portfolio Table 109. Positron Recent Development Table 110. SurgicEye Company Information Table 111. SurgicEye Business Overview Table 112. SurgicEye Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio Table 114. SurgicEye Recent Development Table 115. TeraRecon Company Information Table 116. TeraRecon Business Overview Table 117. TeraRecon Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio Table 119. TeraRecon Recent Development Table 120. Toshiba Company Information Table 121. Toshiba Business Overview Table 122. Toshiba Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio Table 124. Toshiba Recent Development Table 125. Top Grade Healthcare Company Information Table 126. Top Grade Healthcare Business Overview Table 127. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 129. Top Grade Healthcare Recent Development Table 130. Neusoft Group Company Information Table 131. Neusoft Group Business Overview Table 132. Neusoft Group Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio Table 134. Neusoft Group Recent Development Table 135. United Imaging Company Information Table 136. United Imaging Business Overview Table 137. United Imaging Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio Table 139. United Imaging Recent Development Table 140. MinFound Medical Company Information Table 141. MinFound Medical Business Overview Table 142. MinFound Medical Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio Table 144. MinFound Medical Recent Development Table 145. SinoUnion Healthcare Company Information Table 146. SinoUnion Healthcare Business Overview Table 147. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 149. SinoUnion Healthcare Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Nuclear Medicine Diagnostic Equipment Distributors List Table 153. Nuclear Medicine Diagnostic Equipment Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Nuclear Medicine Diagnostic Equipment Product Image Figure 2. Global Nuclear Medicine Diagnostic Equipment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Diagnostic Equipment Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Medicine Diagnostic Equipment Sales (2021-2032) & (K Units) Figure 5. Global Nuclear Medicine Diagnostic Equipment Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PET Image Figure 9. SPECT Image Figure 10. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Nuclear Medicine Diagnostic Equipment Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2032) Figure 13. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2032) Figure 16. Tumor Imaging Image Figure 17. Endocrine System Imaging Image Figure 18. Urinary System Imaging Image Figure 19. Bone Marrow Imaging Image Figure 20. Others Image Figure 21. Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Nuclear Medicine Diagnostic Equipment Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2032) Figure 24. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2032) Figure 27. North America Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 29. U.S. Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 34. Germany Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 41. China Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 49. Brazil Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Nuclear Medicine Diagnostic Equipment Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Nuclear Medicine Diagnostic Equipment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Nuclear Medicine Diagnostic Equipment Revenue (2021-2032) & (US$ Million) Figure 60. North America Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Nuclear Medicine Diagnostic Equipment Revenue (2021-2032) & (US$ Million) Figure 62. Europe Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Nuclear Medicine Diagnostic Equipment Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nuclear Medicine Diagnostic Equipment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Nuclear Medicine Diagnostic Equipment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • PET
  • SPECT
Applications
  • Tumor Imaging
  • Endocrine System Imaging
  • Urinary System Imaging
  • Bone Marrow Imaging
  • Others
Companies covered
  • GE HealthCare
  • Siemens Healthineers
  • CMR Naviscan
  • Compañía Mexicana
  • DDD-Diagnostic
  • Digirad
  • Mediso Medical Imaging Systems
  • Philips
  • Positron
  • SurgicEye
  • TeraRecon
  • Toshiba
  • Top Grade Healthcare
  • Neusoft Group
  • United Imaging
  • MinFound Medical
  • SinoUnion Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nuclear Medicine Diagnostic Equipment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nuclear Medicine Diagnostic Equipment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nuclear Medicine Diagnostic Equipment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nuclear Medicine Diagnostic Equipment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nuclear Medicine Diagnostic Equipment Market Dynamics
  1. 2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
  2. 2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
  3. 2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 Nuclear Medicine Diagnostic Equipment Market by Manufacturers
  1. 3.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nuclear Medicine Diagnostic Equipment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nuclear Medicine Diagnostic Equipment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nuclear Medicine Diagnostic Equipment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclear Medicine Diagnostic Equipment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nuclear Medicine Diagnostic Equipment Manufacturers, Product Type & Application
  7. 3.7 Global Nuclear Medicine Diagnostic Equipment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclear Medicine Diagnostic Equipment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine Diagnostic Equipment Market by Type
  1. 4.1 Nuclear Medicine Diagnostic Equipment Type Introduction
  2. 4.1.1 PET
  3. 4.1.2 SPECT
  4. 4.2 Global Nuclear Medicine Diagnostic Equipment Sales by Type
  5. 4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
  7. 4.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2032)
  8. 4.3 Global Nuclear Medicine Diagnostic Equipment Revenue by Type
  9. 4.3.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
  11. 4.3.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2032)
5 Nuclear Medicine Diagnostic Equipment Market by Application
  1. 5.1 Nuclear Medicine Diagnostic Equipment Application Introduction
  2. 5.1.1 Tumor Imaging
  3. 5.1.2 Endocrine System Imaging
  4. 5.1.3 Urinary System Imaging
  5. 5.1.4 Bone Marrow Imaging
  6. 5.1.5 Others
  7. 5.2 Global Nuclear Medicine Diagnostic Equipment Sales by Application
  8. 5.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
  10. 5.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2032)
  11. 5.3 Global Nuclear Medicine Diagnostic Equipment Revenue by Application
  12. 5.3.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
  14. 5.3.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2032)
6 Global Nuclear Medicine Diagnostic Equipment Sales by Region
  1. 6.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2032)
  3. 6.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026)
  4. 6.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nuclear Medicine Diagnostic Equipment Revenue by Region
  1. 7.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Region
  2. 7.1.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026)
  4. 7.1.3 Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2027-2032)
  5. 7.1.4 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nuclear Medicine Diagnostic Equipment Revenue (2021-2032)
  8. 7.2.2 North America Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nuclear Medicine Diagnostic Equipment Revenue (2021-2032)
  11. 7.3.2 Europe Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GE HealthCare
  2. 8.1.1 GE HealthCare Company Information
  3. 8.1.2 GE HealthCare Business Overview
  4. 8.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
  6. 8.1.5 GE HealthCare Recent Developments
  7. 8.2 Siemens Healthineers
  8. 8.2.1 Siemens Healthineers Company Information
  9. 8.2.2 Siemens Healthineers Business Overview
  10. 8.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
  12. 8.2.5 Siemens Healthineers Recent Developments
  13. 8.3 CMR Naviscan
  14. 8.3.1 CMR Naviscan Company Information
  15. 8.3.2 CMR Naviscan Business Overview
  16. 8.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
  18. 8.3.5 CMR Naviscan Recent Developments
  19. 8.4 Compañía Mexicana
  20. 8.4.1 Compañía Mexicana Company Information
  21. 8.4.2 Compañía Mexicana Business Overview
  22. 8.4.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
  24. 8.4.5 Compañía Mexicana Recent Developments
  25. 8.5 DDD-Diagnostic
  26. 8.5.1 DDD-Diagnostic Company Information
  27. 8.5.2 DDD-Diagnostic Business Overview
  28. 8.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
  30. 8.5.5 DDD-Diagnostic Recent Developments
  31. 8.6 Digirad
  32. 8.6.1 Digirad Company Information
  33. 8.6.2 Digirad Business Overview
  34. 8.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
  36. 8.6.5 Digirad Recent Developments
  37. 8.7 Mediso Medical Imaging Systems
  38. 8.7.1 Mediso Medical Imaging Systems Company Information
  39. 8.7.2 Mediso Medical Imaging Systems Business Overview
  40. 8.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
  42. 8.7.5 Mediso Medical Imaging Systems Recent Developments
  43. 8.8 Philips
  44. 8.8.1 Philips Company Information
  45. 8.8.2 Philips Business Overview
  46. 8.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
  48. 8.8.5 Philips Recent Developments
  49. 8.9 Positron
  50. 8.9.1 Positron Company Information
  51. 8.9.2 Positron Business Overview
  52. 8.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
  54. 8.9.5 Positron Recent Developments
  55. 8.10 SurgicEye
  56. 8.10.1 SurgicEye Company Information
  57. 8.10.2 SurgicEye Business Overview
  58. 8.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
  60. 8.10.5 SurgicEye Recent Developments
  61. 8.11 TeraRecon
  62. 8.11.1 TeraRecon Company Information
  63. 8.11.2 TeraRecon Business Overview
  64. 8.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
  66. 8.11.5 TeraRecon Recent Developments
  67. 8.12 Toshiba
  68. 8.12.1 Toshiba Company Information
  69. 8.12.2 Toshiba Business Overview
  70. 8.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
  72. 8.12.5 Toshiba Recent Developments
  73. 8.13 Top Grade Healthcare
  74. 8.13.1 Top Grade Healthcare Company Information
  75. 8.13.2 Top Grade Healthcare Business Overview
  76. 8.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  78. 8.13.5 Top Grade Healthcare Recent Developments
  79. 8.14 Neusoft Group
  80. 8.14.1 Neusoft Group Company Information
  81. 8.14.2 Neusoft Group Business Overview
  82. 8.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
  84. 8.14.5 Neusoft Group Recent Developments
  85. 8.15 United Imaging
  86. 8.15.1 United Imaging Company Information
  87. 8.15.2 United Imaging Business Overview
  88. 8.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
  90. 8.15.5 United Imaging Recent Developments
  91. 8.16 MinFound Medical
  92. 8.16.1 MinFound Medical Company Information
  93. 8.16.2 MinFound Medical Business Overview
  94. 8.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
  96. 8.16.5 MinFound Medical Recent Developments
  97. 8.17 SinoUnion Healthcare
  98. 8.17.1 SinoUnion Healthcare Company Information
  99. 8.17.2 SinoUnion Healthcare Business Overview
  100. 8.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  102. 8.17.5 SinoUnion Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
  2. 9.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nuclear Medicine Diagnostic Equipment Production Mode & Process
  6. 9.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nuclear Medicine Diagnostic Equipment Distributors
  9. 9.2.3 Nuclear Medicine Diagnostic Equipment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst